Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gene Therapy”

1,925 trials

Showing 20 of 1,925 results

Not applicableStudy completedNCT00038675
What this trial is testing

Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate

Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myeloid LeukemiaPolycythemia Vera+2 more
M.D. Anderson Cancer Center 125
Testing effectiveness (Phase 2)Enrolling By InvitationNCT03999801
What this trial is testing

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy

Who this might be right for
Neovascular Age-related Macular DegenerationWet Macular Degeneration
AbbVie 865
Not applicableActive Not RecruitingNCT07312500
What this trial is testing

Fecal DNA Methylation and Helicobacter Pylori SNPs Tests for Gastric Cancer

Who this might be right for
Gastric (Stomach) Cancer
Fudan University 3,000
Testing effectiveness (Phase 2)WithdrawnNCT02390739
What this trial is testing

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer

Who this might be right for
Metastatic Thyroid Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT01100944
What this trial is testing

PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies

Who this might be right for
ThymomaThymic Carcinoma
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Looking for participantsNCT06399107
What this trial is testing

Investigation Into the Use of BAH243 Lentiviral Vector for Gene Therapy in Treating Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle-Cell Disease With Crisis
Essen Biotech 85
Testing effectiveness (Phase 2)Study completedNCT00001493
What this trial is testing

Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT02556736
What this trial is testing

AGN-151597 (Formerly RST-001) Phase I/II Trial for Advanced Retinitis Pigmentosa

Who this might be right for
Advanced Retinitis Pigmentosa
AbbVie 14
Testing effectiveness (Phase 2)Study completedNCT04129216
What this trial is testing

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer

Who this might be right for
Breast Cancer
Johns Hopkins University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04069533
What this trial is testing

Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A

Who this might be right for
Fanconi Anemia Complementation Group A
Rocket Pharmaceuticals Inc. 7
Testing effectiveness (Phase 2)WithdrawnNCT06690281
What this trial is testing

A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies

Who this might be right for
Gastrointestinal CarcinomaPancreatic CancerHepatocellular Cancer+5 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00019136
What this trial is testing

Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)WithdrawnNCT01531244
What this trial is testing

Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma

Who this might be right for
Melanoma
Washington University School of Medicine
Very early researchNot Yet RecruitingNCT06178432
What this trial is testing

Evaluation of the Safety, Tolerability and Efficacy of Gene Therapy Drug for Late Onset Pompe Disease (LOPD)

Who this might be right for
Pompe Disease (Late-onset)
Huashan Hospital 6
Testing effectiveness (Phase 2)Study completedNCT00300521
What this trial is testing

Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Transplantation
Beijing Chao Yang Hospital 40
Very early researchNot Yet RecruitingNCT06963008
What this trial is testing

A Prospective, Single-center, Open-label Clinical Study to Evaluate the Safety and Efficacy of Inhaled BMD003(CFTR mRNA) in Chinese Adult Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis (CF)Gene Therapy
Peking Union Medical College Hospital 12
Not applicableWithdrawnNCT02006849
What this trial is testing

ACTH Treatment of APOL1- Associated Nephropathy

Who this might be right for
Kidney Disease
Wake Forest University Health Sciences
Early research (Phase 1)Ended earlyNCT01952730
What this trial is testing

Pilot Study of GVAX in Colorectal Cancer Cells

Who this might be right for
Colorectal Cancer
Massachusetts General Hospital 1
Large-scale testing (Phase 3)Active Not RecruitingNCT00999609
What this trial is testing

Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis

Who this might be right for
Inherited Retinal Dystrophy Due to RPE65 MutationsLeber Congenital Amaurosis
Spark Therapeutics, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT00600587
What this trial is testing

Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Guangdong Provincial People's Hospital 24
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation